Silverarc Capital Management »

Terns Pharmaceuticals shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.5M 500k 5.03
2023-06-30 $5.2M 600k 8.75
2023-03-31 $7.9M 668k 11.84
2022-12-31 $7.1M 700k 10.18
2022-09-30 $85k 15k 5.87

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Terns Pharmaceuticals

OrbiMed Advisors
Vivo Capital
VR Adviser
Braidwell
Franklin Resources
Vanguard Group
Fairmount Funds Management
Millennium Management
Henderson Group
Dr. Jeffrey R. Jay, M.D.
Perceptive Advisors
Decheng Capital
Norges Bank Investment Management
Schonfeld Strategic Advisors
Russell Investments

View all funds holding Terns Pharmaceuticals